EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Mortality risk associated with acetylcholinesterase inhibitor use in Parkinson’s disease dementia according to sex and age at disease onset: a nationwide cohort study

Bora Yoon, Hwa Jung Kim

Epidemiology and Health · 11.04.2026 · 48 · e2026015

DOI: 10.4178/epih.e2026015 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Epidemiology and Health, online erschienen am 11.04.2026. Verfasst von Bora Yoon und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Parkinson Disease, Dementia. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Dementia increases mortality risk; however, most studies evaluating acetylcholinesterase inhibitors (AChEIs) have focused on Alzheimer’s disease. The survival effects of AChEIs in Parkinson’s disease dementia (PDD) remain unclear. This study evaluated the association between AChEI use and mortality in PDD, stratified by sex and age at Parkinson’s disease (PD) onset.METHODS: This retrospective cohort study used data from the Korean National Health Insurance Service from January 2002 to December 2021. Patients diagnosed with PDD after PD onset were included. Propensity score matching (2:1) was performed to match AChEI users with non-users. Kaplan–Meier survival analyses and subgroup analyses were conducted according to sex and age at PD onset.RESULTS: AChEI use was associated with a 24% reduction in mortality risk (hazard ratio [HR], 0.76; 95% confidence interval [CI], 0.74 to 0.78; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsParkinson DiseaseDementiaHumansMaleRetrospective StudiesFemaleRepublic of KoreaAge of OnsetAgedAged, 80 and overSex FactorsMiddle AgedCohort Studies

Stichwörter der Autor:innen

Acetylcholinesterase inhibitorDementiaMortalityParkinson diseaseSex

Substanzen

Cholinesterase Inhibitors

Autor:innen und Institutionen

  • Department of Neurology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Konyang University Myunggok Medical Research Institute, Daejeon, Korea.
  • Department of Medical Informatics & Statistics, Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea. hello.hello.hj@gmail.com.

Zitieren

APA

Yoon, B., & Kim, H. J. (2026). Mortality risk associated with acetylcholinesterase inhibitor use in Parkinson’s disease dementia according to sex and age at disease onset: a nationwide cohort study. Epidemiology and Health, 48, e2026015. https://doi.org/10.4178/epih.e2026015

Vancouver

Yoon B, Kim HJ. Mortality risk associated with acetylcholinesterase inhibitor use in Parkinson’s disease dementia according to sex and age at disease onset: a nationwide cohort study. Epidemiology and Health. 2026;48:e2026015. doi:10.4178/epih.e2026015

BibTeX
@article{Yoon2026,
  author = {Yoon, Bora and Kim, Hwa Jung},
  title = {Mortality risk associated with acetylcholinesterase inhibitor use in Parkinson’s disease dementia according to sex and age at disease onset: a nationwide cohort study},
  journal = {Epidemiology and Health},
  year = {2026},
  volume = {48},
  pages = {e2026015},
  doi = {10.4178/epih.e2026015}
}
Kostenlos starten →